⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLYS News
Mineralys Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
MLYS
Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026
globenewswire.com
MLYS
Mineralys Therapeutics Announces Publication of Phase 2 Explore-CKD Trial Results for Lorundrostat in Kidney International
globenewswire.com
MLYS
Mineralys Therapeutics Presents New Lorundrostat Data in Participants with Hypertension and Chronic Kidney Disease at ASN Kidney Week 2026
globenewswire.com
MLYS
Form 8-K
sec.gov
MLYS
Mineralys Therapeutics Expands its Board of Directors with the Appointments of Kristine Peterson and Lonnel Coats
globenewswire.com
MLYS
Mineralys Therapeutics Presents New Data for Lorundrostat at the American Heart Association Hypertension Scientific Sessions 2026
globenewswire.com
MLYS
Mineralys Therapeutics Announces Presentation of New Lorundrostat Data at the American Society of Nephrology (ASN) Kidney Week 2026
globenewswire.com
MLYS
Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026
globenewswire.com
MLYS
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MLYS